Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study
Multiple Sclerosis Journal · 2023
DOI: 10.1177/13524585231154780 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Multiple Sclerosis Journal, 2023. Verfasst von Sydney Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Toronto, St. Michael's Hospital, Toronto, ON, Canada. Hauptthemen laut MEDLINE: COVID-19, Neuromyelitis Optica. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Reports suggest a potential association between coronavirus disease 2019 (COVID-19) vaccines and acute central nervous system (CNS) inflammation.
Objective
The main objective of this study is to describe features of acute CNS inflammation following COVID-19 vaccination.
Methods
A retrospective observational cohort study was performed at the BARLO MS Centre in Toronto, Canada. Clinicians reported acute CNS inflammatory events within 60 days after a COVID-19 vaccine from March 2021 to August 2022. Clinical characteristics were evaluated.
Results
Thirty-eight patients (median age 39 (range: 20–82) years; 60.5% female) presented within 0–55 (median 15) days of a receiving a COVID-19 vaccine and were diagnosed with relapsing remitting multiple sclerosis (MS) ( n = 16), post-vaccine transverse myelitis ( n = 7), clinically isolated syndrome ( n = 5), MS relapse ( n = 4), tumefactive demyelination ( n = 2), myelin oligodendrocyte glycoprotein antibody disease ( n = 1), neuromyelitis optica spectrum disorder ( n = 1), chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids ( n = 1) and primary autoimmune cerebellar ataxia ( n = 1). Twenty-two received acute treatment and 21 started disease-modifying therapy. Sixteen received subsequent COVID-19 vaccination, of which 87.5% had no new or worsening neurological symptoms.
Conclusion
To our knowledge, this is the largest study describing acute CNS inflammation after COVID-19 vaccination. We could not determine whether the number of inflammatory events was higher than expected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Toronto, St. Michael's Hospital, Toronto, ON, Canada.
- Division of Neurology, Department of Medicine, BARLO MS Centre, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
- Division of Neurology, Department of Medicine, BARLO MS Centre, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada Li Ka Shing Knowledge Institute, Toronto, ON, Canada.
ORCID-Profile: Sydney Lee, Kristen M Krysko
Zitieren
APA
Lee, S., Muccilli, A., Schneider, R., Selchen, D., & Krysko, K. M. (2023). Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study. Multiple Sclerosis Journal. https://doi.org/10.1177/13524585231154780
Vancouver
Lee S, Muccilli A, Schneider R, Selchen D, Krysko KM. Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study. Multiple Sclerosis Journal. 2023. doi:10.1177/13524585231154780
BibTeX
@article{Lee2023,
author = {Lee, Sydney and Muccilli, Alexandra and Schneider, Raphael and Selchen, Daniel and Krysko, Kristen M},
title = {Acute central nervous system inflammation following COVID-19 vaccination: An observational cohort study},
journal = {Multiple Sclerosis Journal},
year = {2023},
doi = {10.1177/13524585231154780}
}
EUVIMED